January/February #161 : Medicine Chest - by Laura Whitehorn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Fighting AIDS With Lessons Learned From Black History

Adoption Issues

No Child Left Behind




Hard Return

Female Condom

Medicine Chest

Cancer Cutters?

Cuppa Joe

Treatment: By Design

Green Goddess

Resolution Revolution




Flying United

Precious Little

POZ Picks-Winter Reads

You Said It- January/February 2010

Rubber Soul

The Best of the POZ Blogs-January/February 2010




Editor's Letter-January/February 2010

Your Feedback-January/February 2010

In Memoriam



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


Scroll down to comment on this story.


email print

January / February 2010


Medicine Chest

by Laura Whitehorn

Some people can take lower doses of Sustiva.

Some HIV-positive people may be able to take a reduced dose of the HIV med efavirenz (in Sustiva and Atripla)—if the regular dose produces higher than normal levels of the drug in their blood. Dutch investigators reported this in the October Journal of Acquired Immune Deficiency Syndromes—and said that the lower dose still effectively suppressed HIV.  For some people, this could translate to fewer side effects: Often, those with high efavirenz blood-levels suffer depression, troublesome dreams and sleep interruption.

The only hitch: Efavirenz levels were gauged using therapeutic drug monitoring (TDM, measuring concentrations of drugs in your bloodstream)—not commonly available in this country. So call this a vote for making TDM accessible in the United States.

Search: Sustiva, dose, efavirenz, Atripla, blood-level, depression, therapeutic drug monitoring


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Should the U.S. gay blood ban end?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.